Our findings are consistent with previous studies, we showed that knockdown of YTHDF1 inhibits RNF7 expression, resulting in abnormal ROS accumulation upon DDP treatment in prostate cancer, while overexpression of RNF7 can reverse this effect. The gene discussed is YTHDF1; the disease is prostate carcinoma.